PATRICIA RUS: Open Payments
NPI 1275148280 · PRESCOTT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 15 payments from 8 companies in 2025. Trend: 2023 $705 · 2024 $768 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Lilly USA, LLC | 2 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $32 |
| PFIZER INC. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: GEMTESA, ZORYVE, MOUNJARO, PREVNAR 20, BREZTRI, TRELEGY ELLIPTA, JARDIANCE, EVENITY.
Industry payments across AZ — which companies pay providers there.
